Hydralazine Hydrochloride 71209-0017-11
- Manufacturer
- Cadila Pharmaceuticals Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 29, 2015
- Listing Expires
- December 31, 2026
- Application
- ANDA203845
Need to source Hydralazine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydralazine Hydrochloride | 50 mg/1 |
Drug Class
Arteriolar Vasodilation [PE]Arteriolar Vasodilator [EPC]
Selected Package
71209-0017-11Selected1000 TABLET in 1 BOTTLE (71209-017-11)
Other packages for this product(1)
100 TABLET in 1 BOTTLE (71209-017-05)